Filter
417
Filtered Results: 417
Text search:
leishmaniosis
Featured
Recommendations
48
New Publications
96
Language
Document type
No document type
163
Studies & Reports
89
Guidelines
50
Strategic & Response Plan
33
Manuals
22
Videos
16
Resource Platforms
15
Fact sheets
11
Training Material
6
Situation Updates
5
Infographics
5
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
56
Latin America and the Carribbean
19
Ethiopia
16
Paraguay
13
India
13
Syria
11
Colombia
10
Africa
10
Nepal
9
Kenya
8
Bangladesh
8
Brazil
8
Middle East and North Africa
6
Western and Central Europe
6
Uganda
6
Venezuela
5
Germany
5
Congo, Democratic Republic of
5
Sudan
5
Jordan
4
Bolivia
4
Ghana
3
Nigeria
3
Niger
3
East and Southern Africa
3
Lebanon
3
Zambia
3
South Sudan
3
Iraq
3
Somalia
3
Turkey
2
Iran
2
Burkina Faso
2
Peru
2
Malawi
2
Saudi Arabia
2
South–East Asia Region
2
Eastern Europe
2
Angola
2
Ecuador
2
Pakistan
2
North Macedonia
1
Mexico
1
Sierra Leone
1
Togo
1
China
1
Rwanda
1
Cameroon
1
Albania
1
Afghanistan
1
Morocco
1
Qatar
1
Mauritania
1
Mozambique
1
Cambodia
1
Asia
1
Tanzania
1
West and Central Africa
1
North America
1
Tunisia
1
South Africa
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Chad
1
Libya
1
Indonesia
1
Liberia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
66
Public Health
40
Key Resources
18
Capacity Building
5
Women & Child Health
5
Pharmacy & Technologies
5
Toolboxes
NTDs
139
Planetary Health
24
HIV
17
Rapid Response
12
Conflict
12
Global Health Education
12
COVID-19
10
Refugee
9
Caregiver
7
TB
4
Pharmacy
3
NCDs
3
Mental Health
2
Natural Hazards
2
Zika
2
Disability
1
Cholera
1
Ebola
1
Health Financing Toolbox
1
Polio
1
AMR
1
Leishmaniose cutanée : un important problèmede santé
La leishmaniose cutanée est une maladie potentiellement grave et défigurante. Les personnes atteintes de leishmaniose cutanée ont une ou plusieurs lésions durables sur la peau, le plus souvent sans fièvre ni symptômes généraux. L'impac...
Website last accessed on 07.06.2023
Stopleishmania.org is an initiative of the VISAVET Health Surveillance Centre (UCM), the National Centre of Microbiology (ISCIII), the Animal Protection Centre (Madrid City Council) and the Directorate of Public Health (Regional Government of Madrid). This proj...
National Guideline
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Frequently Asked Questions on Visceral Leishmaniasis
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ...
Rreport of a WHO Consultative Meeting Kolkata India 2012
Leitlinie der Deutschen Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG) in Zusammenarbeit mit der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) und der Deutschen Dermatologischen Gesellschaft
2nd edition
El manual tiene por objetivo ampliar los conocimientos sobre la enfermedad y aspira a ser una herramienta de trabajo para que el personal de salud y los equipos de gestión presten apoyo a los ministerios de salud en sus respectivos procesos de estructuración de los servicios de salud, así como en...
La leishmaniasis es un problema creciente de salud pública en el contextomundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis cutánea que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el ...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and...
